Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/DROPERIDOL KALCEKS 2,5 MG/ML SOLUCION INYECTABLE EFG

Approved

STANDARD

DROPERIDOL KALCEKS 2,5 MG/ML SOLUCION INYECTABLE EFG

Kalceks As🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 7, 2021
Approval ID: 31877e00d28a79bb
Company: Kalceks As
Type: Standard

Approval Details

Approval Id: 31877e00d28a79bb
Drug Cima Aemps Name: DROPERIDOL KALCEKS 2,5 MG/ML SOLUCION INYECTABLE EFG
Register Number: 86009
Holder Company Name: Kalceks As
Marketing Company Name: Grindeks Kalceks Espana S.L.
Authorization Date: 2021-06-07
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 2.5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Kalceks As

Active Ingredients

DROPERIDOL

2,5 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 7, 2021

Approval ID

31877e00d28a79bb

Type

Standard

Back to CIMA-AEMPS Approvals

DROPERIDOL KALCEKS 2,5 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details